Navigation Links
IRSF receives $1 million matching gift
Date:10/26/2009

anyone with a passion for curing neurological disorders to join our campaign to reverse Rett syndrome."

The campaign, announced during Rett Syndrome Awareness Month, also coincides with the 10-year anniversary of the breakthrough discovery of the causative MECP2 gene, which was made by the lab of IRSF-funded researcher and key advisor, Dr. Huda Zoghbi at Baylor College of Medicine. "The last several years have been filled with exciting developments in Rett syndrome research, and major progress has occurred in the biomedical research arena," said Dr. Antony Horton, Chief Scientific Officer of IRSF. "IRSF has played a critical role in advancing the most important scientific breakthroughs in the last decade, including Dr. Adrian Bird's pivotal research demonstrating the reversibility of Rett syndrome symptoms in mice. This exciting proof-of-concept makes us very optimistic about the possibility of pharmacological reversal of Rett syndrome. This aggressive fundraising campaign will provide a much needed boost for drug discovery and development for this purpose, and various target compounds are being identified for testing in a clinical setting."

Around the country, at major research institutions, is a community of scientists committed to curing Rett syndrome and other neurological disorders. They are in position to benefit from funding allocations being finalized by the IRSF's Scientific Review Board and the National Institutes of Health (NIH). The NIH is the largest single source of medical research funds in the world, and has great influence on shaping scientific research agendas. Decision-makers there are looking to support collaborative research aimed at securing significant clinical results, research that represents a partnership between patient advocates, basic researchers and industry.

With this in mind, the IRSF scientific staff and expert advisors from academia and industry recently developed a comprehensive program for moving basi
'/>"/>

Contact: Kathryn Kissam
804-519-6231
International Rett Syndrome Foundation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Rutgers Genetics receives $7.8 million for autism research
2. Herr receives Heinz Award for Technology, the Economy and Employment
3. UCI receives $5M from Edwards Lifesciences
4. Yu receives research funding from the Wallace H. Coulter Foundation
5. UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC
6. UC Riverside biologist receives prestigious MacArthur Fellowship
7. UC Irvine receives $2.18M to explore nano advancements in DNA sequencing
8. Penn biochemist receives NIH New Innovators Award
9. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
10. Einstein researcher receives NIH grant to explore epigenetic regulation of the human genome
11. Alaska graduate program in sustainability receives $3.2 million award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... July 30, 2015 after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... microbial communities and the growth of sedimentary rock at ... a surprising discovery about the geological record of life ... sequences of sedimentary rock are dated, and how scientists ... We found microbes change the rate at which calcium ...
... a combination of individual scientific skills, expertise and ... offer the opportunity to build a highly focused ... the urgent need for bringing new antibiotic compounds ... and other antimicrobial agents have saved millions of ...
... Assessment of Climate Change for the Baltic Sea Basin (BACC), ... of past and possible future climate change in the region, ... northern and mid-Europe. One of the key findings is that ... up to five degrees Celsius from now to 2100. More ...
Cached Biology News:Hot springs microbes hold key to dating sedimentary rocks, researchers say 2Unique fungal collection could hold key to future antibiotics 2Unique fungal collection could hold key to future antibiotics 3Climate change in the Baltic Sea basin -- past, present and future 2Climate change in the Baltic Sea basin -- past, present and future 3
(Date:7/29/2015)... -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; ... to progressing its ground-breaking technology platforms to Phase 1 ... the Company delivers the best value for shareholders. ... said the Company currently had an extensive program of ... and academic partnerships and initiatives, and he was working ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... the Company,s Chief Financial Officer has resigned.  The Company ... Financial Officer who retired in December 2014, as full ... a permanent successor.     Andy Ashworth ... and ensure a smooth transition.  Andy was the Company,s ...
(Date:7/29/2015)... July 29, 2015  AsureQuality and Ubiquitome have ... for applications in food and primary production sectors. ... real-time PCR device, the Freedom4. AsureQuality ... to the supermarket shelf for producers, processors and ... in animal disease control and pest management and ...
(Date:7/29/2015)... -- Research and Markets ( ... "Global Biosimilars Market, 2015 - 2025" ... Biosimilars Market, 2015 - 2025, report provides an ... With the blockbuster biologics losing patent protection and ... being viewed as viable substitutes to the highly ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3
... Stallergenes,has been granted with the marketing authorisation for ... PEI (Paul Ehrlich,Institute), the biological branch of the ... results of the paediatric pivotal study (VO52),Stallergenes will ... indications., Stallergenes will launch Oralair(R) Grasses in ...
... Clinical Trial Capability into the Frontage ... ... Frontage Laboratories,( http://www.frontagelab.com ) (Malvern and Exton, PA USA ... pre-clinical and,drug development services to the pharmaceutical industry, announced today,it ...
... for Thursday, June 26th at 2:30pm ET, NEW ... ) today announced that Michael S. Weiss, the Company,s,Chairman ... the,Jefferies & Co. Healthcare Conference being held in New ... live on Thursday, June 26th at,2:30pm ET and will ...
Cached Biology Technology:Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany 2Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany 3Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 2Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 3Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 4Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference 2
... Raji cells were cultured in RPMI 1640 medium ... log phase of growth. In order to ... were fixed in acetone-methanol. The cells are ... slide, with each wells surface specifically treated to ...
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... trays are disposable trays that ... that have been blotted onto ... eight 10.5 cm x 5 ... cut from blotted membrane and ...
... the state-of-the-art in permanent mounting media. ... preservation of immunohistochemical organic insoluble substrates ... New Fuchsin, and any other organic ... sections. Clarin can be used for ...
Biology Products: